Precigen Inc (NASDAQ:PGEN) currently has a daily average trading volume of 1.71M but it saw 3718593 shares traded in last market. With a market cap of 559.38M USD, the company’s current market price of $1.91 came rising about 12.35 while comparing to the previous closing price of $1.70. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.93 and as low as $0.65. In the recent trading on the day, stock has struck highest price mark of $1.7 while lowest mark touched by it was $1.97.
Taking a look at 20-day trading activity of Precigen Inc (PGEN) gives us an average price of $1.3890, while its current price level is -1.04% below from 52-week high level whereas it is 193.26% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.0911 while that of 200 days or SMA-200 reads an average of $1.1877. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.49% during that period while stretching the period over a month that decreases to 10.42%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 76.50 which implies that the stock is in overbought territory.
Cantor Fitzgerald issued its recommendations for the stock as it initiated the price target for the stock is $7.
Over the week, PGEN’s stock price is moving 28.19% up while it is 78.50% when we observe its performance for the past one month. Year-to-date it is 70.54% up and over the past year, the stock is showing an upside performance of 36.43%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.06 while estimate for next year EPS is -0.46. In next quarter, company is expected to be making quarterly sales of $733.33k as analysts are expecting the sales for current fiscal year at $4M and seeing the company making $20.38M in sales next year. Moreover, analysts are in estimates of $1.3M for current-quarter revenue.
Currently, Precigen Inc’s total number of outstanding shares is 292.87M with 10.18% of that held by the insiders while 63.83% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -232.08% and return on equity (ROE) at -137.46%. Stock’s beta reads 1.62. Stock has a price to book (P/B) ratio of 10.10 while price to sale or P/S ratio amounts to 141.26. Its return on asset (ROA) is -101.81% on average.
